APRIL 2021 – Verdure Sciences is proud to announce Longvida® curcumin extract (Solid Lipid Curcumin Particle - SLCP™) is now available in Brazil after receiving ANVISA approval through an exclusive distribution partner in this territory, Kilyos Nutrition. Verdure and Kilyos have forged this new partnership to work in collaboration to offer Longvida®, which is a proprietary Curcuma long extract uniquely positioned to support an expanding market targeting joint health, cognitive health, mood, sports nutrition, vascular health, and more. 

curcumin-powder-featureLongvida (Solid Lipid Curcumin Particle - SLCP™) is a patented and proprietary turmeric extract standardized to curcumin and total curcuminoids. It is backed by clinical research, safety, rigorous quality control, sustainability, traceability, and global acceptance, and now also available in Brazil with the recent ANVISA approval. "We are pleased with the approval of LongVida for food supplementation. Curcumin is an ingredient of proven effectiveness in promoting health and wellness for individuals,” explains José João Name, MD, PhD, director of Kilyos Nutrition.He continued, "Additionally, offering the Brazilian population the best available source of curcumin makes us very excited about the range of possibilities to be developed.” Dr. João Name went on to say, “We would like to thank our partner Verdure Sciences for the opportunity of including LongVida in our portfolio and for providing us with the full support to obtain the approval of curcumin from ANVISA, for the first time in Brazil, in the food supplementation category. We most certainly will obtain incredibly good results from this partnership!”


Verdure Sciences is excited about this development which is a result of its collaboration with Kilyos Nutrition. “We are honored to offer Longvida® to the Brazilian market via Kilyos and their strong customer base which includes both nutritional and pharmaceutical companies. It is a testament to LongVida’s global acceptance and footprint which is a result of two decades of continuous investment in its safety, efficacy, quality, traceability and sustainability. In addition LongVida offers multifaceted health benefits as a result of clinical studies in healthy human subjects conducted in global demographics evaluating a multitude of biological markers," stated Ajay Patel, Founder & CEO with Verdure Sciences.†

Read more on Nutraceutical Business Review: Longvida receives ANVISA approval in Brazil
Read more on Nutritional Outlook: Verdure Sciences' turmeric ingredient, Longvida receives ANVISA approval 
Read more on NutraIngredients-LATAM: Verdure's Longvida gets Brazilian approval via Kilyos Nutrition partnership


† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

longvida logo - hr +NO TAG




About Verdure Sciences®:  Verdure Sciences® manages ingredient innovation through the integration of supply network, production, and research platforms. With an expanding pipeline of proprietary, standardized botanical ingredients supported by pharmacokinetic, pharmacodynamic, and clinical research profiles, we work toward our unified vision to offer safe, effective ingredient solutions. Verdure Sciences® is a registered trademark of Verdure Sciences®, Inc.
  • Visit for more information. Visit for the most current patent and trademark information. 


These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Please note that the physiological activity of the ingredient(s) described herein is supported by the referenced clinical trial reports. Marketers of finished products containing the ingredient(s) described herein are responsible for determining whether claims made for such products are lawful and in compliance with the laws of the country in which they will market the products.
For our most current patent information, please visit: